FTX has been reported to act as a tumor promoter in various types of cancer, including osteosarcoma [62], colorectal cancer [63], gliomas [64], lung adenocarcinoma [65], and gastric cancer [66], where it was found to be closely associated with a poor prognosis. This evidence concerns the gene FTX and osteosarcoma.